Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001042167-25-000017
Filing Date
2025-03-14
Accepted
2025-03-14 17:22:25
Documents
1
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3913
  Complete submission text file 0001042167-25-000017.txt   5557
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Issuer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address
Katzovitz Loren Mark (Reporting) CIK: 0002032343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13602 | Film No.: 25741363